Circulating Inflammatory Factor Levels in the Early Phase of COVID-19 are Associated with the Progression of Respiratory Failure: A Single-Center Retrospective Study
Xiaoli Xiang,Zhicheng Zhang,Ying Liu,Wenxuan Xu,Ju Gong,Sheng Yu,Lan Zhang,Tingwang Jiang
DOI: https://doi.org/10.2147/jir.s430221
IF: 4.5
2023-11-14
Journal of Inflammation Research
Abstract:Xiaoli Xiang, 1, 2 Zhicheng Zhang, 1 Ying Liu, 1 Wenxuan Xu, 1 Ju Gong, 3 Sheng Yu, 4 Lan Zhang, 5 Tingwang Jiang 1 1 Department of Key Laboratory, Affiliated Changshu Hospital of Nantong University, Changshu, People's Republic of China; 2 Department of Ophthalmology, Affiliated Changshu Hospital of Nantong University, Changshu, People's Republic of China; 3 Department of Emergency Medicine, Affiliated Changshu Hospital of Nantong University, Changshu, People's Republic of China; 4 Department of Critical Care Medicine, Affiliated Changshu Hospital of Nantong University, Changshu, People's Republic of China; 5 Information Center, Affiliated Changshu Hospital of Nantong University, Changshu, People's Republic of China Correspondence: Tingwang Jiang, Department of Key Laboratory, Affiliated Changshu Hospital of Nantong University, No. 68 Haiyu Nan Road, Changshu, Jiangsu Province, People's Republic of China, Tel +86 15995921425, Fax +86 512-52277250, Email Purpose: To evaluate the potential relationships between serum interleukin (IL)-2, IL-4, IL-6, IL-10, IL-17, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α levels and occurrence of respiratory failure in patients with early-stage COVID-19 disease. Patients and Methods: We analyzed clinical characteristics, laboratory parameters, and immunoinflammatory markers in 302 patients diagnosed with SARS-CoV-2 infection who required hospitalization at Changshu Hospital of Nantong University. IL-2, IL-4, IL-6, IL-10, IL-17, IFN-γ, and TNF-α levels in the peripheral blood of patients hospitalized five days after disease onset were measured using multiplex bead-based flow fluorescent immunoassay (MBFFI). Results: Patients with respiratory failure had higher serum IL-4 [0 (0, 0.54) pg/mL], IL-6 [40.76 (12.33, 90.28) pg/mL], IL-10 [6.65 (4.12, 11.34) pg/mL], and IL-17 [9.48 (4.31, 12.13) pg/mL] levels than patients without respiratory failure (P=0.042, P< 0.0001, P=0.012, and P=0.036, respectively). Serum IL-2, IFN-γ, and TNF-α levels were not significantly different between the two groups. The occurrence of respiratory failure was positively correlated with sex (R=0.122, P=0.034), lactic acid (R=0.193, P=0.007), white blood cell count (R=0.121, P=0.038), erythrocyte distribution width (R=0.131, P=0.024), thyrocalcitonin (R=0.280, P< 0.0001), and D-dimer levels (R=0.214, P< 0.0001) but negatively correlated with oxygen partial pressure (R=− 0.208, P=0.004), oxygen saturation (R=− 0.220, P=0.002), lymphocyte count (R=− 0.129, P=0.026), and calcium (R=− 0.152, P=0.042). Among the immunoinflammatory biomarkers, the occurrence of respiratory failure was positively correlated with IL-4 (R=− 0.117, P=0.042), IL-6 (R=0.206, P< 0.0001), IL-10 (R=0.145, P=0.012), and IL-17 (R=0.121, P=0.036) levels. Conclusion: Serum levels of pro-inflammatory cytokines IL-6 and IL-17 and anti-inflammatory cytokines IL-4 and IL-10 were significantly elevated in patients with respiratory failure and weakly positively correlated with the occurrence of respiratory failure. Further studies are required to explore these key immune mechanisms to help clinicians better manage acute complications, long-term sequelae, and possible future COVID-19 variants and be flexible in managing future epidemics and similar public health threats. Keywords: COVID-19, respiratory failure, hypoxemia, biomarkers, cytokines, disease progression Coronavirus disease 2019 (COVID-19) is the most serious acute respiratory infectious disease globally in recent years, 1 and the resulting pandemic has affected patients in various ways. The symptoms of COVID-19 are typically caused by viral replication and disappear within 1–2 weeks. 2 Most patients had self-limiting infections and recovered without hospitalization, while 15–20% of them face excessive inflammation caused by a large number of cytokines, which is known as a cytokine storm and eventually leads to alveolar damage and respiratory failure (RF). 3 Following acute infection, more serious events occur when myeloid cells such as monocytes and macrophages generate a cytokine storm with the swift release of IL-6, IL-1b, CXCL10, CCL7, and other inflammatory molecules. 4 Thus, hyperinflammation is a major problem in COVID-19 cases. 5 As the pathological damage caused by COVID-19 involves the immune system, any factor that regulates the immune response may likewise regulate the consequences of COVID-19. 6 The pathological features of human severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) remain to be completely discovered; however its immune pathogenesis is known -Abstract Truncated-
immunology